Characterization of [125I]RTI-121 binding to dopamine transporter in vitro

Acta Pharmacologica Sinica

Volumn 18, Issue 2, 1997, Pages 115-120

  Chen, Nian Hang ^a   Ding, Jian Hua ^a   Wang, You Lin ^a   Reith, Maarten E A ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

corpus striatum; dopamine; RTI 121 binding; synaptosomes; tropanes

Indexed keywords

1 [1 (2 BENZO[B]THIENYL)CYCLOHEXYL]PIPERIDINE; 1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; BUFFER; CALCIUM ION; COCAINE; COCAINE DERIVATIVE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; IODINE 125; MAGNESIUM ION; MAZINDOL; PERGOLIDE; QUINPIROLE; STEPHOLIDINE; SULPIRIDE; CARRIER PROTEIN; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; DRUG DERIVATIVE;

AMINE TRANSPORT; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BINDING KINETICS; BINDING SITE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING; DRUG INHIBITION; MALE; MODEL; NONHUMAN; RAT; ANIMAL; IN VITRO STUDY; METABOLISM; SPRAGUE DAWLEY RAT; SYNAPTOSOME;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CARRIER PROTEINS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; MALE; PERGOLIDE; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES;

EID: 0031082414     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Uhl GR, Johnson PS. Neurotransmitter transporters: three important gene families for neuronal function. J Exp Biol 1994; 196: 229-36.
2. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606-12.
3. Ross SB. Pharmacological and toxicological exploitation of amine transporters. Trends Pharmacol Sci 1987; 8: 227-31.
4. Boja JW, Kopajtic TA. Ion channel inhibitors may function as potential moculators of cocaine binding. Neuropharmacol 1993; 32: 229-43.
5. 2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem 1993; 61: 764-7.
6. 3H]mazindol. J Pharmacol Exp Ther 1990; 253: 1206-14.
7. 3H]tropane to the dopamine uptake carrier. J Neurochem 1993; 61: 167-77.
8. 125I] iodophenyl) tropane-2β-carboxylic acid isopropyl ester. Mol Pharmacol 1995; 47: 779-86.
9. De Lean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, redioligand assay and physiological dose-response curves. Am J Physiol 1978; 235: E79-E102.
10. Xu SX, Yu LP, Han Y, Chen Y, Jin GZ. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Acta Pharmacol Sin 1989; 10: 104-10.
11. Weiland GA, Molinoff PB. Quantitative analysis of drug-receptor interactions. I. Determination of kinetic and equilibrium properties. Life Sci 1981; 29: 313-20.
12. 125I]RTI-121 binding sites in human striatum and medial temporal lobe. J Pharmacol Exp Ther 1995; 274: 1473-83.
13. 125I]RTI-121. Synapse 1995; 21: 364-72.
14. 3H]WIN 35428 binding to the dopamine uptake carrier. I. Effect of tonicity and buffer composition. J Neurosci Methods 1994; 51: 23-30.
15. Carroll FI, Kotian P, Dehghani A, Gray JL, Kuzemko MA, Parham KA, et al. Cocaine and 3βig;-(4′-substituted phenyl)